NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal

Publication Date

2026

Content Type

article

PubMed ID:

41499716

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS